Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
A Phase 3, Open-Label, Single-Arm Trial Evaluating the Safety, Tolerability, and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine in Children With Sickle Cell Disease Previously Immunized With 23 Valent pneumococcal polysacchride Vaccine. Pfizer Completed 13-valent Pneumoccocal Conjugate Vaccine 3 B1851013 King Faisal Specialist Hospital and Research Center (Riyadh)
View 711 - 711 From 711